Publicado 6 números por año
ISSN Imprimir: 1045-4403
ISSN En Línea: 2162-6502
Indexed in
Prostaglandin E—A Powerful Anabolic Agent for Generalized or Site-Specific Bone Formation
SINOPSIS
Prostaglandins are locally secreted, rapidly metabolized, biologically active fatty acids first identified in the prostate. The role of prostaglandins in the inflammatory response has been widely studied. However, some prostaglandins, particularly those of the E series (PGEs), can suppress inflammation, making it difficult to understand the local events and their sequence. This bimodal potential of the PGEs has been poorly understood in skeletal biology, causing the initial report of PGEs as mediators of bone resorption to persist for more than two decades, despite ample evidence to the contrary. This resulted in part from the power of any initial report to overrule subsequent conflicting views and in part on the exclusive reliance on in vitro data to explain in vivo phenomena. Over a decade ago, the potential of PGEs as authentic anabolic skeletal agents was demonstrated convincingly in vivo by both systemic and local delivery. The potential clinical applications of the PGEs in skeletal biology have not yet been developed. Our purpose is to review the reasons for the delayed discovery of the true skeletal effects of the PGEs and to describe applications for this technology. With the development of appropriate delivery systems, one can anticipate widespread clinical applications of the PGEs to accelerate skeletal repair, and to treat skeletal pathologies and trauma.
-
Bodine Peter V.N., Billiard Julia, Moran Robert A., Ponce-de-Leon Helga, McLarney Sean, Mangine Annamarie, Scrimo Melissa J., Bhat Ramesh A., Stauffer Barbara, Green Jack, Stein Gary S., Lian Jane B., Komm Barry S., The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis, Journal of Cellular Biochemistry, 96, 6, 2005. Crossref
-
Bradley J. D., Cleverly D. G., Burns A. M., Helm N. B., Schmid M. J., Marx D. B., Cullen D. M., Reinhardt R. A., Cyclooxygenase-2 inhibitor reduces simvastatin-induced bone morphogenetic protein-2 and bone formation in vivo, Journal of Periodontal Research, 42, 3, 2007. Crossref
-
Atik O Sahap, Uslu M Murad, Eksioglu Fatih, Satana Tolgay, Etiology of Senile Osteoporosis, Clinical Orthopaedics & Related Research, 443, 2006. Crossref
-
Preston Rhonda D., Meinberg Trudy A., Payne Jeffrey B., Schmid Marian J., Lee Hsi-Ming, Golub Lorne M., Marx David B., Reinhardt Richard A., Inflammatory mediator release following bone grafting in humans: a pilot study, Journal of Clinical Periodontology, 34, 9, 2007. Crossref
-
Liu Xin-Ming, Wiswall Andrew T., Rutledge John E., Akhter Mohammed P., Cullen Diane M., Reinhardt Richard A., Wang Dong, Osteotropic β-cyclodextrin for local bone regeneration, Biomaterials, 29, 11, 2008. Crossref
-
Choi Mi Ran, Das Nando Dulal, Jung Kyoung Hwa, Kim Seung Hyun, Kim Hyun Young, Kim Kyung Suk, Chai Young Gyu, Gene expression during long-term culture of mesenchymal stem cells obtained from patients with amyotrophic lateral sclerosis, BioChip Journal, 6, 4, 2012. Crossref
-
Pan Huaizhong, Sima Monika, Miller Scott C., Kopečková Pavla, Yang Jiyuan, Kopeček Jindřich, Efficiency of high molecular weight backbone degradable HPMA copolymer–Prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats, Biomaterials, 34, 27, 2013. Crossref
-
Pan Huaizhong, Kopečková Pavla, Wang Dong, Yang Jiyuan, Miller Scott, Kopeček JindŘich, Water-soluble HPMA copolymer—prostaglandin E1conjugates containing a cathepsin K sensitive spacer, Journal of Drug Targeting, 14, 6, 2006. Crossref
-
Miller S. C., Pan H., Wang D., Bowman B. M., Kopečková P., Kopeček J., Feasibility of Using a Bone-Targeted, Macromolecular Delivery System Coupled with Prostaglandin E1 to Promote Bone Formation in Aged, Estrogen-Deficient Rats, Pharmaceutical Research, 25, 12, 2008. Crossref
-
Ripoll Vera M., Irvine Katharine M., Ravasi Timothy, Sweet Matthew J., Hume David A., GpnmbIs Induced in Macrophages by IFN-γ and Lipopolysaccharide and Acts as a Feedback Regulator of Proinflammatory Responses, The Journal of Immunology, 178, 10, 2007. Crossref
-
Pahl Madeleine V., Vaziri Nosratola D., Yuan Jun, Adler Sharon G., Upregulation of Monocyte/Macrophage HGFIN (Gpnmb/Osteoactivin) Expression in End-Stage Renal Disease, Clinical Journal of the American Society of Nephrology, 5, 1, 2010. Crossref
-
Janssens Katrien, ten Dijke Peter, Janssens Sophie, Van Hul Wim, Transforming Growth Factor-β1 to the Bone, Endocrine Reviews, 26, 6, 2005. Crossref
-
Itani Oussama, Tsang Reginald, Normal bone and mineral physiology and metabolism, in Neonatal Nutrition and Metabolism, 2006. Crossref
-
Krischak G. D., Augat P., Blakytny R., Claes L., Kinzl L., Beck A., The non-steroidal anti-inflammatory drug diclofenac reduces appearance of osteoblasts in bone defect healing in rats, Archives of Orthopaedic and Trauma Surgery, 127, 6, 2007. Crossref
-
Kobayashi Yasuhiro, Take Ikuko, Yamashita Teruhito, Mizoguchi Toshihide, Ninomiya Tadashi, Hattori Toshimi, Kurihara Saburo, Ozawa Hidehiro, Udagawa Nobuyuki, Takahashi Naoyuki, Prostaglandin E2 Receptors EP2 and EP4 Are Down-regulated during Differentiation of Mouse Osteoclasts from Their Precursors, Journal of Biological Chemistry, 280, 25, 2005. Crossref